RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Squamous Cell Carcinoma - Pipeline Review, Q4 2010
Dec 2010 - 27 pages - $500
Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged
Nov 2011 - 48 pages - $5,700
Squamous Cell Carcinoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 73 pages - $1,000
Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report
Nov 2010 - 1535 pages - $1,495
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Non-Small Cell Lung Cancer - Pipeline Review, Q1 2011
Feb 2011 - 538 pages - $500
Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy
Feb 2011 - 6 pages - $500
Squamous Cell Carcinoma - Pipeline Review, H2 2011
Aug 2011 - 236 pages - $500
Renal Cell Carcinoma - Pipeline Review, Q3 2011
Jul 2011 - 390 pages - $500
Small-Cell Lung Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 81 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Therapeutic target
Oncology del
Lung cancer del
Squamous cell carcinoma del
Year
2008 del

Browse By

Industry sector
Antibody-based diagnostics
Biomarker-based diagnostics
CAT
Genetic diagnostics
Imaging
MRI
Nuclear medicine
Other
Self-test systems
Supplies
Test systems
Ultrasound
X-ray

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us